DK1845954T3 - Oralt opløsende sammensætning af olanzapin og donepzil - Google Patents

Oralt opløsende sammensætning af olanzapin og donepzil

Info

Publication number
DK1845954T3
DK1845954T3 DK06701464.7T DK06701464T DK1845954T3 DK 1845954 T3 DK1845954 T3 DK 1845954T3 DK 06701464 T DK06701464 T DK 06701464T DK 1845954 T3 DK1845954 T3 DK 1845954T3
Authority
DK
Denmark
Prior art keywords
olanzapine
donepzil
orally dissolving
dissolving composition
composition
Prior art date
Application number
DK06701464.7T
Other languages
English (en)
Inventor
Vesna Kroselj
Sasa Kolaric
Renata Jakse
Miha Vrbinc
Original Assignee
Krka Tovarna Zdravil D D Novo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil D D Novo filed Critical Krka Tovarna Zdravil D D Novo
Application granted granted Critical
Publication of DK1845954T3 publication Critical patent/DK1845954T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
DK06701464.7T 2005-01-14 2006-01-13 Oralt opløsende sammensætning af olanzapin og donepzil DK1845954T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05000664A EP1681048A1 (en) 2005-01-14 2005-01-14 Orally disintegrating composition of olanzapine or donepezil
PCT/EP2006/000284 WO2006074951A2 (en) 2005-01-14 2006-01-13 Orally disintegrating composition of olanzapine or donepezil

Publications (1)

Publication Number Publication Date
DK1845954T3 true DK1845954T3 (da) 2010-08-16

Family

ID=34933289

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06701464.7T DK1845954T3 (da) 2005-01-14 2006-01-13 Oralt opløsende sammensætning af olanzapin og donepzil

Country Status (15)

Country Link
EP (2) EP1681048A1 (da)
AT (1) ATE465719T1 (da)
AU (1) AU2006205817A1 (da)
DE (1) DE602006013940D1 (da)
DK (1) DK1845954T3 (da)
EA (1) EA013742B1 (da)
ES (1) ES2344959T3 (da)
HR (1) HRP20100399T1 (da)
NO (1) NO20074087L (da)
PL (1) PL1845954T3 (da)
PT (1) PT1845954E (da)
SI (1) SI1845954T1 (da)
UA (1) UA89394C2 (da)
WO (1) WO2006074951A2 (da)
ZA (1) ZA200706692B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879382B2 (en) 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
CA2650498A1 (en) * 2006-03-31 2007-10-11 Rubicon Research Private Limited Orally disintegrating tablets
GB0614586D0 (en) * 2006-07-22 2006-08-30 Pliva Istrazivacki Inst D O O Pharmaceutical Formulation
HUE038022T4 (hu) * 2006-10-02 2023-02-28 Spepharm Ag Nem mukoadhezív filmdózisformák
DE602007011792D1 (de) 2006-10-27 2011-02-17 Fmc Corp Gemeinsam aufbereitete mikrokristalline cellulose und zuckeralkohol als hilfsstoff für tablettenformulierungen
KR20090119993A (ko) 2007-03-13 2009-11-23 다이닛본 스미토모 세이야꾸 가부시끼가이샤 구강내 붕괴정
EP2572705B1 (en) 2007-10-01 2017-09-13 Laboratorios Lesvi, S.L. Orodispersible tablets
CN101756917A (zh) * 2008-10-24 2010-06-30 北京科信必成医药科技发展有限公司 盐酸多奈哌齐口腔崩解片及其制备方法
WO2010070611A1 (en) * 2008-12-18 2010-06-24 Ranbaxy Laboratories Limited Atazanavir formulations
EP2198857A1 (en) 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
TR200903293A1 (tr) * 2009-04-28 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan olanzapin tablet.
TR201002084A1 (tr) * 2010-03-19 2011-10-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Oral yolla dağılan donepezil tablet formülasyonları ve hazırlama yöntemi
FR2962331B1 (fr) * 2010-07-06 2020-04-24 Ethypharm Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre
WO2012014012A1 (es) * 2010-07-27 2012-02-02 Laboratorios Andrómaco S.A. Procedimiento para preparar comprimidos de disolucion rapida oral que comprenden la forma i de olanzapina, los comprimidos obtenidos y su uso para el tratamiento de la esquizofrenia.
BR112014007366B1 (pt) 2011-10-05 2020-09-15 Dupont Nutrition Usa, Inc Processo para fabricar uma composição estabilizadora compreendendo extrusão em duas etapas, composição estabilizadora de celulose microcristalina e produto alimentício comestível e suspensão industrial compreendendo a mesma
WO2013052118A1 (en) 2011-10-05 2013-04-11 Fmc Corporation Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
WO2013085810A2 (en) 2011-12-09 2013-06-13 Fmc Corporation Co-attrited stabilizer composition
WO2014027975A2 (en) * 2012-08-17 2014-02-20 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Novel orally administered pharmaceutical formulations
FR2999432B1 (fr) * 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
CN104510717B (zh) * 2013-09-27 2019-02-05 江苏豪森药业集团有限公司 奥氮平口崩片及其制备方法
CN108261399A (zh) * 2016-12-30 2018-07-10 江苏豪森药业集团有限公司 奥氮平口腔崩解片及其制备方法
CN108926543A (zh) * 2017-05-26 2018-12-04 万全万特制药江苏有限公司 一种奥氮平口腔崩解片及其制备方法
CN109498544A (zh) * 2017-09-15 2019-03-22 万全万特制药江苏有限公司 稳定的奥氮平组合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1260215E (pt) * 2000-03-01 2009-09-03 Eisai R&D Man Co Ltd Comprimido de desintegração rápida que contém poli(álcool vinílico)
AU2002255196A1 (en) * 2002-04-18 2003-10-27 Dr. Reddy's Laboratories Ltd. Rapidly dispersing solid oral compositions

Also Published As

Publication number Publication date
ES2344959T3 (es) 2010-09-10
AU2006205817A1 (en) 2006-07-20
DE602006013940D1 (de) 2010-06-10
PT1845954E (pt) 2010-08-02
SI1845954T1 (sl) 2010-08-31
NO20074087L (no) 2007-10-09
WO2006074951A2 (en) 2006-07-20
ZA200706692B (en) 2008-07-30
PL1845954T3 (pl) 2010-10-29
WO2006074951A3 (en) 2007-04-26
ATE465719T1 (de) 2010-05-15
EP1845954A2 (en) 2007-10-24
EA013742B1 (ru) 2010-06-30
EA200701462A1 (ru) 2008-02-28
UA89394C2 (uk) 2010-01-25
EP1845954B1 (en) 2010-04-28
HRP20100399T1 (hr) 2010-09-30
EP1681048A1 (en) 2006-07-19

Similar Documents

Publication Publication Date Title
NO20074087L (no) Oralt disintegrert sammensetning av olanzapin eller donepezil
HN2012001162A (es) Triazolopiridinas
NO20092611L (no) Krystallinsk faststoff Rasagilin base
DK1907373T3 (da) Fremgangsmåder til fremstillingen af 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindolin-1,3-dionforbindelser
TW200621313A (en) Pharmaceutical compositions
NO20084850L (no) MGLUR5 modulatorer I
NI201100143A (es) Composición farmacéutica sólida que comprende amlodipina y losartan.
CR10497A (es) Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor gpr38
DK1858342T3 (da) Fremgangsmåde til fremstilling af ernæringssammensætninger
NO20082793L (no) Nye tiofenderivater
DK1695710T3 (da) Krystallinsk betad-form af ivabradinhydrochlorid, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende denne
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
ECSP066376A (es) FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
WO2008127364A3 (en) Antiviral compounds and use thereof
DK1869035T3 (da) Hidtil ukendt krystallinsk form af tiotropiumbromid og fremgangsmåde til fremstilling deraf
HN2006014095A (es) Forma cristalina ortorrombica del maleato de asenapina
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
DK1810676T3 (da) Levetiracetam formuleringer og fremgangsmåder til deres fremstilling
EA200601608A1 (ru) Способ производства твёрдой фармацевтической композиции
ATE429906T1 (de) Trockene aripiprazolformulierungen
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
BRPI0607645A2 (pt) sais de derivados de hexaidrofenantridina substituìdos com 6-heterociclila
DK1879580T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolinderivater som lægemidler til behandling af infertilitet
DK1881830T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet